SCHEMBL96488

SCHEMBL96488

[O]CCCCF

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL180222 0.96
SCHEMBL2094653 0.96
SCHEMBL8500348 0.96
SCHEMBL2541524 0.96
SCHEMBL8498984 0.96
SCHEMBL1699318 0.96
SCHEMBL8500220 0.96
SCHEMBL7857443 0.96
SCHEMBL8497937 0.96
SCHEMBL8500174 0.96

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 3651 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230348421-A1 5-HT2A RECEPTOR INHIBITOR OR INVERSE AGONIST, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF LUYE INNOMIND PHARMA SHIJIAZHUANG CO., LTD. (CN) 2023-11-02 US claimed
CN-116730981-A 5-HT 2A Receptor inhibitor or inverse agonist, preparation method and application thereof 山东绿叶制药有限公司 2023-09-12 CN claimed
CN-114728933-B 5-HT 2A Receptor inhibitor or inverse agonist, preparation method and application thereof 山东绿叶制药有限公司 2023-06-16 CN claimed
EP-4186893-A1 5-HT2A RECEPTOR INHIBITOR OR INVERSE AGONIST, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF Geneora Pharma (Shijiazhuang) Co., Ltd. (CN) 2023-05-31 EP claimed
CN-115189021-A Lithium ion battery non-aqueous electrolyte and lithium ion battery 深圳新宙邦科技股份有限公司 2022-10-14 CN claimed
CN-114728933-A 5-HT2AReceptor inhibitor or inverse agonist, preparation method and application thereof 山东绿叶制药有限公司 2022-07-08 CN claimed
US-11345693-B2 Compounds, salts thereof and methods for treatment of diseases ACADIA PHARMACEUTICALS INC. (US) 2022-05-31 US claimed
US-20210122713-A1 COMPOUNDS, SALTS THEREOF AND METHODS FOR TREATMENT OF DISEASES ACADIA PHARMACEUTICALS INC. (US) 2021-04-29 US claimed
US-20200270239-A1 COMPOUNDS, SALTS THEREOF AND METHODS FOR TREATMENT OF DISEASES ACADIA PHARMACEUTICALS INC. (US) 2020-08-27 US claimed
EP-3672954-A1 COMPOUNDS, SALTS THEREOF AND METHODS FOR TREATMENT OF DISEASES Acadia Pharmaceuticals Inc. (US) 2020-07-01 EP claimed
US-20080287517-A1 Pyrazole Derivatives as Cb1 Modulators ASTRAZENECA AB (SE) 2008-11-20 US claimed
WO-2008130320-A2 NOVEL N- (8-HETEROARYLTETRAHYDRONAPHTALENE-2YL) OR N- (5- HETEROARYLCHROMANE-3-YL) CARBOXAMIDE DERIVATIVES FOR THE TREATMENT OF PAIN ASTRAZENECA AB (SE) 2008-10-30 WO claimed
WO-2008082198-A1 ANTIFUNGAL TRIAZOLE DERIVATIVES, METHOD FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION CONTAINING SAME DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2008-07-10 WO claimed
US-20080131367-A1 Composition For Diagnosing Amyloid-Related Diseases Mori, Hiroshi (JP) 2008-06-05 US claimed
EP-1910331-A1 PYRAZOLE DERIVATIVES AS CBl MODULATORS AstraZeneca AB (SE) 2008-04-16 EP claimed
EP-1815872-A1 COMPOSITION FOR AMYLOID-ASSOCIATED DISEASE DIAGNOSIS Nagasaki University (JP) 2007-08-08 EP claimed
WO-2007010217-A1 PYRAZOLE DERIVATIVES AS CBl MODULATORS ASTRAZENECA AB (SE) 2007-01-25 WO claimed
US-7164011-B2 Lincomycin derivatives possessing antibacterial activity VICURON PHARMACEUTICALS, INC. (US) 2007-01-16 US claimed
US-6017931-A Insecticidal compositions containing n-(substituted phenylmethyl)-4-[bis(substituted phenyl)methyl]piperidines FMC CORPORATION 2000-01-25 US claimed
US-5888475-A KIT FOR RAPID SYNTHESIS OF LABELED COCAINE DERIVATIVES THAT BIND DOPAMINE TRANSPORTER, COMPRISING SAID COCAINE DERIVATIVE, PHASE TRANSFER CATALYST, RADIOACTIVELY LABELED POTASSIUM FLUORIDE EMORY UNIVERSITY (US) 1999-03-30 US claimed